An experimental therapy using human embryonic stem cells to treat degenerative eye diseases has proved safe and effective in animal studies, and may begin early human trials in the next few months if it receives approval from the Food and Drug Administration. If granted approval, the therapy will be the second embryonic-stem-cell-based treatment to progress to human trials, and it will provide a test case for further applications of stem cells.
A Stem-Cell Therapy for Blindness
Claude Lemieux’s brain is being donated to the Boston University CTE Center to research the long-term...
99% of chemicals in our food right now were added without FDA approval. Many were added...
